10 Stocks Targeted By Short Sellers Recently
A curious outcome of the turmoil ushered in by the coronavirus pandemic was the historic tussle between retail and institutional investors.
Bellerophon Therapeutics Inc. (BLPH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.18 | 4,000 | $40,708.00 | 4,000 | 2020-09-10 | Filing | |
| $12.87 | 2,600 | $33,454.20 | 60,913 | 2020-06-08 | Filing | |
| $12.72 | 4,986 | $63,441.86 | 58,313 | 2020-06-05 | Filing | |
| $0.39 | 7,193 | $2,773.62 | 592,922 | 2019-11-25 | Filing | |
| $0.37 | 1,050 | $393.54 | 585,729 | 2019-11-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.10 | 1,076,841 | $111,776.10 | 0 | 2023-10-13 | Filing | |
| $0.83 | 134,421 | $111,569.43 | 1,076,841 | 2023-06-07 | Filing | |
| $10.00 | 9,455 | $94,550.00 | 1,723 | 2023-05-18 | Filing | |
| $9.46 | 560,000 | $5,297,600.00 | 1,211,262 | 2023-05-18 | Filing | |
| $5.48 | 400,000 | $2,192,000.00 | 609,231 | 2021-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
Hedge Funds Are Coming Back To Bellerophon Therapeutics, Inc. (BLPH)
A whopping number of 13F filings filed with U.S.
10 Best Nano Cap Stocks To Buy in 2021
Small companies with market capitalizations of less than $50 million tend to witness a lot of growth after a recession because investors seem willing to take risks on the back of positive sentiment afforded...
Here is What Hedge Funds Think About Bellerophon Therapeutics, Inc. (BLPH)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Is Bellerophon Therapeutics, Inc. (BLPH) A Good Stock To Buy?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Is Bellerophon Therapeutics, Inc. (BLPH) Going to Burn These Hedge Funds?
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018.
Hedge Fund and Insider Trading News: David Einhorn, Silver Lake Partners, Bellerophon Therapeutics Inc (BLPH), Titan Pharmaceuticals, Inc. (TTNP), Spark Energy Inc (SPKE) and More
Hedge fund manager David Einhorn is blasting Tesla again. "Like Lehman, we think the deception is about to catch up to TSLA," Einhorn said in an investor letter Friday.
Hedge Fund and Insider Trading News: Tiger Global Management, Citadel LLC, Elliott Management, Square, Inc. (SQ), Tiffany & Co. (TIF), Global Brass and Copper Holdings Inc (BRSS), and More
Chase Coleman’s Tiger Global Management has invested more than $1 billion in Fiat Chrysler Automobiles NV after more than doubling its position in the carmaker since the end of June. The U.S.
Squashed Takeovers And Positive Test Results Propelling These Stocks Higher
Three stocks are making some major noise in today’s trading session, with gains of over 15% for all three.
Hedge Funds Disagree with the Market on One of These Two Falling Stocks
Shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH), and Tuesday Morning Corporation (NASDAQ:TUES) are down significantly in the afternoon trade.
Billionaire Hedge Funds
